NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-CA-21-093 from the NIH Guide for Grants and Contracts
Funding Opportunity PA-21-268 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) hereby notify recipient organizations holding specific types of NIH grants, listed in the full Funding Opportunity Announcement (FOA), that applications for change of recipient organization may be submitted to this FOA. This assumes such a change is programmatically permitted for the particular grant. Applications for change of recipient organization are considered prior approval requests (as described in Section 8.1.2.7 of the NIH Grants Policy Statement) and will be routed for consideration directly to the Grants Management Specialist named in the current award. Although requests for change of recipient organization may be submitted through this FOA, there is no guarantee that an award will be transferred to the new organization. All applicants are encouraged to discuss potential requests with the awarding IC before submission.
Funding Opportunity RFA-HG-21-025 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits R01 grant applications that propose independent research projects that are within the scientific mission areas of the National Human Genome Research Institute (NHGRI). This program is intended to support New Investigators from diverse backgrounds, including those from groups underrepresented in the health-related sciences.
Funding Opportunity RFA-DE-22-003 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to solicit research to better understand the epidemiology and biology of oral human papillomavirus (HPV) infection, its acquisition and persistence, in people living with HIV and elucidate the initial mechanisms related to HPV-associated oral and oropharyngeal cancers and warts in the context of HIV.
Funding Opportunity PAR-21-269 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages solicits applications that propose research designed to test training, mentoring, and networking interventions intended to enhance research-oriented individuals' interest, motivation, persistence and preparedness for careers in the biomedical research workforce. Funded projects are expected to produce research findings that will guide the design and implementation of potential interventions in a variety of academic settings and career levels to enhance the diversity of the biomedical research workforce.
Notice NOT-OD-21-092 from the NIH Guide for Grants and Contracts
Notice NOT-HD-21-038 from the NIH Guide for Grants and Contracts
Notice NOT-AI-21-061 from the NIH Guide for Grants and Contracts
Notice NOT-AG-21-030 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DA-22-029 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support research project applications that are developmental and exploratory in nature to expand our knowledge on the basic neurobiology of the interrelationship between sleep and substance use disorders (SUDs). These mechanistic studies will not only offer an insight into the fundamental processes that link substance use disorders to disorders of sleep regulation and vice-versa but may also have implications for managing risk for the development of SUDs and identifying new targets for prevention and therapeutics.
Funding Opportunity RFA-DE-22-004 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to solicit research to better understand the epidemiology and biology of oral human papillomavirus (HPV) infection, its acquisition and persistence, in people living with HIV and elucidate the initial mechanisms related to HPV-associated oral and oropharyngeal cancers and warts in the context of HIV.
Notice NOT-OD-21-137 from the NIH Guide for Grants and Contracts
Notice NOT-RM-21-030 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-127 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-21-204 from the NIH Guide for Grants and Contracts. The National Eye Institute (NEI) supports investigator-initiated, complex, multi-center and other high resource risk epidemiologic studies under the cooperative agreement mechanism, UG1 activity code. Specifically, the purpose of this Funding Opportunity Announcement (FOA) is to support new and innovative ocular epidemiology research.
Funding Opportunity RFA-MH-21-241 from the NIH Guide for Grants and Contracts. Companion of RFA-MH-21-240 This Funding Opportunity Announcement (FOA) encourages research that addresses major research gaps identified by the United States Preventive Services Task Force (USPSTF): 1) Identify who is at increased risk for perinatal depression and would benefit the most from preventive interventions; and 2) Determine ways to improve the delivery of interventions to prevent perinatal depression. This FOA emphasizes underserved populations.
Funding Opportunity RFA-MH-21-240 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages research that addresses major research gaps identified by the United States Preventive Services Task Force (USPSTF): 1) Identify who is at increased risk for perinatal depression and would benefit the most from preventive interventions; and 2) Determine ways to improve the delivery of interventions to prevent perinatal depression. This FOA emphasizes underserved populations.
Funding Opportunity RFA-ES-21-006 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research seeking to understand mechanisms of chemical toxicity and to identify potential molecular/genetic targets that reduce acute effects of chemical threat agents that affect the eyes and lungs. These discoveries can lead to exploration of therapeutic countermeasures through early stage development efforts supported by the Countermeasures Against Chemical Threats (CounterACT) NIH-wide program, a component within the Chemical Countermeasures Research Program (CCRP).
Notice NOT-AI-21-062 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-21-249 from the NIH Guide for Grants and Contracts. This funding Opportunity Announcement (FOA) encourages Multiple Principal Investigator (Multi-PD/PI) applications from United States (U.S.) and Indian institution as bilateral collaborations that will advance science and technology important to understanding, preventing, and treating blinding eye diseases, visual disorders, and their complications. Areas of Research Collaboration: Applications are encouraged from organization/institutions that propose to conduct research on the basic biology and/or genetics of ophthalmic diseases through collaborations with Indian investigators on the following: diabetic retinopathy, glaucoma, age-related macular degeneration, retinitis pigmentosa, including rare and genetic diseases such as congenital cataracts, as well as other eye conditions such as ocular inflammation/uveitis, refractive error, low vision, and corneal injury. Basic, translational, or epidemiological research maybe proposed. Clinical trials will not be supported under this FOA.